NCT06943664 2026-02-18
Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 2 Not yet recruiting
Clinical Trials
12 trialsNCT02662504 2026-02-05
MesoPDT
University Hospital, Lille
Phase 2 Completed
NCT04836429 2026-02-04
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Roswell Park Cancer Institute
Phase 1 Terminated
NCT02153229 2025-12-26
MPM-PDT
Abramson Cancer Center at Penn Medicine
Phase 2 Active not recruiting
NCT03678350 2025-05-11
Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
Roswell Park Cancer Institute
Phase 1 Active not recruiting
NCT01854684 2022-07-22
Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery
Roswell Park Cancer Institute
Phase 1 Completed
NCT03564054 2019-12-18
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
University of Florida
Phase NA Terminated
NCT02106559 2019-03-21
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy
Ohio State University Comprehensive Cancer Center
Phase NA Withdrawn
NCT02702700 2019-03-20
PDT-lipo
Centre Hospitalier Universitaire Vaudois
Phase 1 Terminated
NCT03346304 2019-02-01
PEARL
University College, London
Phase 2/3 Withdrawn
NCT01668823 2014-07-31
Photodynamic Therapy in Treating Patients With Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT00984243 2012-11-15
PDT
Mayo Clinic
Phase NA Completed